Stripe Anthropic OpenAI commit $500M to Intercept nonprofit for broad respiratory virus countermeasures
AI labs and payments infrastructure are funding real-world pathogen control at $500M scale. The move extends computational protein design and air filtration from COVID response into permanent public infrastructure. Parallel to Frontier, it addresses missing commercial incentives for broad-spectrum respiratory protection.
Intercept was announced in June 2026 as a nonprofit modeled on Stripe's Frontier carbon removal program. Nan Ransohoff and Charlie Petty lead the effort. Initial grants target David Veesler's University of Washington work on computationally designed proteins and RNA countermeasures that address rhinoviruses plus influenza simultaneously rather than single-strain vaccines.
AXIOM: Intercept publishes first multi-virus nasal protein trial results by Q4 2028 showing at least 40% reduction in symptomatic respiratory days.
Sources (3)
- [1]Primary Source(https://www.technologyreview.com/2026/06/24/1139621/stripe-anthropic-and-openai-are-backing-an-effort-to-stop-respiratory-infections/)
- [2]Supporting Source(https://www.nature.com/articles/s41586-023-04567-8)
- [3]Supporting Source(https://frontierclimate.com/2024-report)